Bradley Saenger
Financieel Directeur/CFO bij TONIX PHARMACEUTICALS HOLDING CORP.
Vermogen: 16 $ op 30-04-2024
Profiel
Bradley Saenger is currently a Director at Tonix Pharma Holdings Ltd.
and the Chief Financial Officer & Treasurer at Tonix Pharmaceuticals Holding Corp.
He previously worked as an Associate Director-Accounting at Vertex Pharmaceuticals, Inc. from 2011 to 2012 and as a Manager-Corporate Accounting & Consolidations at Alere, Inc. from 2007 to 2011.
Mr. Saenger completed his undergraduate degree at the University of South Africa.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-04-2024 | 99 ( 0.00% ) | 16 $ | 30-04-2024 |
Actieve functies van Bradley Saenger
| Bedrijven | Functie | Begin |
|---|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Financieel Directeur/CFO | 01-02-2016 |
| Tonix Pharma Holdings Ltd. | Directeur/Bestuurslid | 01-11-2015 |
Eerdere bekende functies van Bradley Saenger
| Bedrijven | Functie | Einde |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Comptroller/Controller/Auditor | 01-12-2012 |
| ALERE INC | Financieel Directeur/CFO | 01-09-2011 |
Opleiding van Bradley Saenger
| University of South Africa | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| TONIX PHARMACEUTICALS HOLDING CORP. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Alere, Inc.
 Alere, Inc. Medical SpecialtiesHealth Technology Alere, Inc. engages in developing, manufacturing, and marketing consumer and professional medical diagnostic products. It operates through the following segments: Professional Diagnostics, Consumer Diagnostics, and Other Non-Reportable. The Professional Diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests. The Consumer Diagnostics segment consists of manufacturing operations. The Other Non-Reportable segment includes Alere Home Monitoring, which distributes PT and INR coagulation; monitors and facilitates the distribution of equipment; and supplies to power and control customers' implanted ventricular assist devices and VADs. It also provides telemonitoring services that allow VAD coordinators to monitor patients soon after discharge and receive alerts when critical patient values fall outside pre-established ranges. The company was founded by Ronald Zwanziger on May 11, 2001 and is headquartered in Abbott Park, IL. | Health Technology |
| Tonix Pharma Holdings Ltd. |
